Lipid Keratopathy: Histopathology, Major Differential Diagnoses and The Importance of Clinical Correlation.
Schnyder corneal dystrophy
corneal arcus
corneal neovascularisation
herpes zoster keratitis
lipid keratopathy
vision loss
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
04 May 2023
04 May 2023
Historique:
received:
02
02
2023
revised:
18
04
2023
accepted:
28
04
2023
medline:
13
5
2023
pubmed:
13
5
2023
entrez:
13
5
2023
Statut:
epublish
Résumé
Lipid keratopathy (LK) is a rare ophthalmological condition characterized by a progressive reduction in visual acuity caused by corneal opacification due to central lipid accumulation. LK is characterized by lipid deposits, cholesterol clefts, and neovascularization (NV) leading to disruption in corneal optical quality. LK classification includes a primary and secondary form which depend on pre-existing corneal or systemic disorders and the evidence of NV. Secondary LK is typically associated with a prior occurrence of herpetic infection, such as herpes zoster keratitis. Patients with LK usually present with progressive vision loss and dense cream-colored corneal opacification. Treatment modalities include conservative and surgical approaches focused on corneal NV elimination. When evaluating corneal lipidosis, it is crucial to consider a range of differential diagnoses, including corneal arcus, Schnyder corneal dystrophy, and other corneal deposit conditions. We report a case of a 62-year-old male with herpes zoster keratitis complicated with LK. He presented with painless progressive vision loss and corneal scarring, which raised suspicion about LK diagnosis. This paper emphasizes the importance of correlating clinical and histological findings for accurate LK diagnosis.
Identifiants
pubmed: 37175019
pii: diagnostics13091628
doi: 10.3390/diagnostics13091628
pmc: PMC10178412
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Arch Ophthalmol. 2005 Oct;123(10):1435-8
pubmed: 16219739
Case Rep Ophthalmol Med. 2012;2012:731413
pubmed: 22649744
Prog Retin Eye Res. 2002 Mar;21(2):169-224
pubmed: 12062534
Ophthalmol Ther. 2020 Dec;9(4):833-852
pubmed: 33058067
Br J Ophthalmol. 1988 May;72(5):338-43
pubmed: 3395592
Dev Ophthalmol. 2011;48:67-96
pubmed: 21540632
J Pharm Bioallied Sci. 2015 Apr;7(Suppl 1):S14-5
pubmed: 26015693
BMC Ophthalmol. 2018 Sep 17;18(1):250
pubmed: 30223810